Revvity Debt to Equity Ratio 2010-2024 | RVTY
Revvity Debt/Equity Ratio Historical Data | |||
---|---|---|---|
Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
2024-09-30 | $4.85B | $7.92B | 0.61 |
2024-06-30 | $5.56B | $7.87B | 0.71 |
2024-03-31 | $5.59B | $7.85B | 0.71 |
2023-12-31 | $5.69B | $7.87B | 0.72 |
2023-09-30 | $5.73B | $7.69B | 0.74 |
2023-06-30 | $6.35B | $7.87B | 0.81 |
2023-03-31 | $6.60B | $8.03B | 0.82 |
2022-12-31 | $6.75B | $7.38B | 0.91 |
2022-09-30 | $6.76B | $7.07B | 0.96 |
2022-06-30 | $7.02B | $7.17B | 0.98 |
2022-03-31 | $7.66B | $7.19B | 1.07 |
2021-12-31 | $7.86B | $7.14B | 1.10 |
2021-09-30 | $7.94B | $6.96B | 1.14 |
2021-06-30 | $4.50B | $4.24B | 1.06 |
2021-03-31 | $4.76B | $4.00B | 1.19 |
2020-12-31 | $4.23B | $3.74B | 1.13 |
2020-09-30 | $3.63B | $3.23B | 1.12 |
2020-06-30 | $3.67B | $2.97B | 1.24 |
2020-03-31 | $3.63B | $2.76B | 1.31 |
2019-12-31 | $3.73B | $2.81B | 1.32 |
2019-09-30 | $3.78B | $2.71B | 1.40 |
2019-06-30 | $3.69B | $2.71B | 1.36 |
2019-03-31 | $3.45B | $2.64B | 1.31 |
2018-12-31 | $3.39B | $2.59B | 1.31 |
2018-09-30 | $3.29B | $2.57B | 1.28 |
2018-06-30 | $3.44B | $2.52B | 1.37 |
2018-03-31 | $3.57B | $2.56B | 1.40 |
2017-12-31 | $3.59B | $2.50B | 1.43 |
2017-09-30 | $2.20B | $2.54B | 0.87 |
2017-06-30 | $2.17B | $2.44B | 0.89 |
2017-03-31 | $2.13B | $2.21B | 0.97 |
2016-12-31 | $2.12B | $2.15B | 0.99 |
2016-09-30 | $2.17B | $2.14B | 1.02 |
2016-06-30 | $2.11B | $2.09B | 1.01 |
2016-03-31 | $2.16B | $2.05B | 1.06 |
2015-12-31 | $2.06B | $2.11B | 0.97 |
2015-09-30 | $1.98B | $2.05B | 0.96 |
2015-06-30 | $1.96B | $2.12B | 0.93 |
2015-03-31 | $1.97B | $2.06B | 0.96 |
2014-12-31 | $2.09B | $2.04B | 1.02 |
2014-09-30 | $1.82B | $2.06B | 0.88 |
2014-06-30 | $1.88B | $2.06B | 0.92 |
2014-03-31 | $1.94B | $2.03B | 0.96 |
2013-12-31 | $1.95B | $1.99B | 0.98 |
2013-09-30 | $1.93B | $1.92B | 1.01 |
2013-06-30 | $1.95B | $1.86B | 1.05 |
2013-03-31 | $1.97B | $1.83B | 1.08 |
2012-12-31 | $1.96B | $1.94B | 1.01 |
2012-09-30 | $1.95B | $1.94B | 1.00 |
2012-06-30 | $1.92B | $1.89B | 1.02 |
2012-03-31 | $1.98B | $1.88B | 1.05 |
2011-12-31 | $2.01B | $1.84B | 1.09 |
2011-09-30 | $1.46B | $1.95B | 0.75 |
2011-06-30 | $1.64B | $1.96B | 0.84 |
2011-03-31 | $1.40B | $1.91B | 0.73 |
2010-12-31 | $1.28B | $1.93B | 0.67 |
2010-09-30 | $1.54B | $1.71B | 0.90 |
2010-06-30 | $1.50B | $1.64B | 0.91 |
2010-03-31 | $1.40B | $1.63B | 0.86 |
2009-12-31 | $1.43B | $1.63B | 0.88 |
2009-09-30 | $1.46B | $1.60B | 0.91 |
2009-06-30 | $1.37B | $1.57B | 0.87 |
2009-03-31 | $1.35B | $1.51B | 0.89 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $15.535B | $2.751B |
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $96.890B | 12.02 |
Cencora (COR) | United States | $46.107B | 17.62 |
DiDi Global (DIDIY) | China | $23.233B | 0.00 |
ICON (ICLR) | Ireland | $18.679B | 16.64 |
Avantor (AVTR) | United States | $15.498B | 23.24 |
Natera (NTRA) | United States | $15.385B | 0.00 |
Viatris (VTRS) | United States | $13.858B | 4.22 |
BioMerieux (BMXMF) | France | $13.601B | 0.00 |
Solventum (SOLV) | United States | $12.636B | 0.00 |
CochLear (CHEOY) | Australia | $12.565B | 0.00 |
Medpace Holdings (MEDP) | United States | $10.202B | 28.74 |
Charles River Laboratories (CRL) | United States | $9.742B | 18.41 |
Sonic Healthcare (SKHHY) | Australia | $8.273B | 0.00 |
HealthEquity (HQY) | United States | $7.792B | 42.29 |
Doximity (DOCS) | United States | $7.787B | 49.34 |
Bausch + Lomb (BLCO) | Canada | $6.975B | 32.47 |
Life Times (LTH) | United States | $4.762B | 31.52 |
PACS (PACS) | United States | $4.502B | 0.00 |
Sotera Health (SHC) | United States | $4.367B | 23.36 |
Organon (OGN) | United States | $4.239B | 4.28 |
Surgery Partners (SGRY) | United States | $3.778B | 41.86 |
BrightSpring Health Services (BTSG) | United States | $3.070B | 65.30 |
Ardent Health Partners (ARDT) | United States | $2.577B | 0.00 |
Alignment Healthcare (ALHC) | United States | $2.546B | 0.00 |
Concentras Parent (CON) | United States | $2.480B | 0.00 |
Premier (PINC) | United States | $2.271B | 11.34 |
GoodRx Holdings (GDRX) | United States | $2.254B | 84.86 |
GeneDx Holdings (WGS) | United States | $2.057B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
Teladoc Health (TDOC) | United States | $1.575B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $1.507B | 7.57 |
Progyny (PGNY) | United States | $1.425B | 25.06 |
Establishment Labs Holdings (ESTA) | $1.338B | 0.00 | |
Pediatrix Medical (MD) | United States | $1.319B | 12.91 |
CareDx (CDNA) | United States | $1.228B | 0.00 |
Agilon Health (AGL) | United States | $1.123B | 0.00 |
Embecta (EMBC) | United States | $0.864B | 5.76 |
InnovAge Holding (INNV) | United States | $0.822B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
SBC Medicals (SBC) | United States | $0.722B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.488B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.483B | 0.00 |
Enhabit (EHAB) | United States | $0.382B | 33.04 |
DocGo (DCGO) | United States | $0.355B | 13.35 |
COMPASS Pathways (CMPS) | United Kingdom | $0.309B | 0.00 |
Sera Prognostics (SERA) | United States | $0.255B | 0.00 |
ModivCare (MODV) | United States | $0.232B | 7.37 |
Beauty Health (SKIN) | United States | $0.211B | 0.00 |
Biodesix (BDSX) | United States | $0.195B | 0.00 |
LifeMD (LFMD) | United States | $0.192B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.178B | 0.00 |
MultiPlan (MPLN) | United States | $0.136B | 0.00 |
Nutex Health (NUTX) | United States | $0.127B | 0.00 |
So-Young (SY) | China | $0.092B | 22.35 |
Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.059B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
OncoCyte (OCX) | United States | $0.049B | 0.00 |
NeueHealth (NEUE) | United States | $0.041B | 1.63 |
Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.036B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
Oncology Institute (TOI) | United States | $0.021B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
XWELL (XWEL) | United States | $0.009B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
KindlyMD (KDLY) | United States | $0.005B | 0.00 |
ISpecimen (ISPC) | United States | $0.004B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.001B | 0.00 |